HeartSciences Inc.: amends loan, extends note maturity to Jan 29, 2027

What happened

• The filing reports that HeartSciences Inc and Front Range Ventures LLC entered into Amendment No. 8 to the Loan Agreement and the No. 4 Amended and Restated Secured Promissory Note on Sep 29, 2026.
• The parties agreed to extend the maturity of the note to the earlier to occur of (x) two business days after closing of the proposed business combination between the company and Fortitude Mining Holdings, Inc., announced Jun 23, 2026, and (y) Jan 29, 2027.
• The filing states the original loan was a secured promissory note dated Apr 24, 2020 for $500,000 and that the note accrued interest at a rate of 12% per annum, compounded annually.

Key details

• Original loan: $500,000, evidenced by a secured promissory note dated Apr 24, 2020.
• Interest: 12% per annum, compounded annually; accrued unpaid interest as of Sep 30, 2026 must be paid on or before Sep 30, 2026, and all accrued unpaid interest thereafter is payable on the maturity date.
• Maturity: extended to the earlier of (x) two business days after closing of the announced proposed business combination with Fortitude Mining Holdings, Inc. or (y) Jan 29, 2027.
• Early repayment: the company may elect to repay all or any part before the maturity date, provided any repayment is at least $50,000 and is applied first to accrued interest and then to principal.

Why it may matter

• Item 1.01 was reported: entry into a material definitive agreement (Amendment No. 8 to the Loan Agreement and the No. 4 Amended and Restated Secured Promissory Note), describing revised maturity and interest payment terms.
• Item 2.03 was reported as to creation of a direct financial obligation, to the extent required by applicable rules.
• The filing does not show why the insider traded or why the company acted.